The FDA has resolved Eli Lilly's tirzepatide shortage, but localized supply issues persist. Meanwhile, Hims & Hers Health's ...

S hares of Hims & Hers (NYSE: HIMS) fell as much as 15% on Thursday after news that Eli Lilly's (NYSE: LLY) GLP-1 drug was taken off the shortage list by the FDA. This could impac ...

The company has been doing incredibly well, and revenue as well as profits have skyrocketed in recent quarters. Shares of ...

Levi Strauss & Co.’s (LEVI) shares plunged 7.7% after reporting third-quarter fiscal 2024 net revenues of $1,517 million, missing the Zacks Consensus Estimate of $1,552 million. Shares of ...

But a growing number of users have had serious health effects. Our reporting found that some widely held beliefs about the drug’s safety aren’t true → Megan Twohey It’s a myth, for ...

External affairs minister S Jaishankar meets with Sajith Premadasa, Sri Lanka's opposition leader, during his visit to Colombo. Jaishankar is the first foreign dignitary to visit since the NPP ...

This time, I’m shifting gears to focus… Authorities in Cape Verde have hit out at claims of mass food poisoning linked to the tourist destination, saying health and safety is an “absolute ...

Covering Netflix News Independently Since 2013. What’s on Netflix is not owned by or affiliated with Netflix or any of its partners in any capacity. The authors of this site also have no affiliation ...